SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 7 of 37
Health
Here’s when to finally expect children under 5 to be eligible for a COVID vaccine
By
Andrew Marquardt
February 1, 2022
Health
New York City will home-deliver free antiviral pills to COVID-19 patients
By
Ian Fisher
and
Bloomberg
January 31, 2022
Politics
Pfizer CEO Albert Bourla and Europe’s leaders negotiated a vaccine megadeal by private text. Now those messages may come out
By
David Meyer
January 28, 2022
Health
Pfizer and Moderna boosters keep you safe from Omicron hospitalization, CDC says
By
Fiona Rutherford
and
Bloomberg
January 21, 2022
International
Pfizer’s vaccine didn’t just ward off COVID—it may have saved Germany’s economy last year
By
Christiaan Hetzner
January 21, 2022
Health
Anthony Fauci says FDA could approve COVID vaccines for children under 5 by the end of February
By
Eamon Barrett
January 20, 2022
Health
BioNTech and London A.I. firm create ‘early warning system’ to spot dangerous new COVID-19 variants before they spread
By
Jeremy Kahn
January 12, 2022
Health
We were promised Pfizer pills. Where are the other COVID treatments?
By
Nicole Goodkind
January 11, 2022
Health
Pushback grows against fourth COVID vaccine doses, with experts urging caution over expanding booster campaigns
By
David Meyer
January 11, 2022
Health
Pfizer is testing a hybrid COVID vaccine, mixing its original with a new formulation that shields against Omicron
By
Riley Griffin
and
Bloomberg
January 11, 2022
Health
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
By
Erika Fry
and
Nicolas Rapp
January 5, 2022
Health
CDC panel approves Pfizer boosters for younger teens
By
Lauran Neergaard
,
Mike Stobbe
and
The Associated Press
January 5, 2022
Health
FDA clears Pfizer boosters for 12-to-15 year-olds
By
Lauran Neergaard
and
The Associated Press
January 3, 2022
Finance
Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By
Jeremy Kahn
December 29, 2021
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By
David Meyer
December 27, 2021
Most Popular
Success
Meet a 23-year-old electrician who was a 'good student' but skipped college to join Gen Z's blue-collar revolution. He...
By
Nick Lichtenberg
Success
Zoom’s CEO agrees with Bill Gates, Jensen Huang, and Jamie Dimon: A 3-day workweek is coming soon thanks to AI
By
Emma Burleigh
Success
Billionaire who sold two companies to Coca-Cola says he tries to convince people not to become entrepreneurs: 'Every...
By
Dave Smith